Alex Delbridge
InvestorAssociate at Omega Funds
Cambridge, Massachusetts
Writes $100K – $5M checks · typically $1.5M
Find your path to Alex
264 people in our graph share verified history with Alex — schools, employers, funds. One of them is your warm intro.
Esther GilmoreunlockedAlex: together at University of Melbourne (2004)
Alex: together at Scorpion Therapeutics
Alex: together at BridgeBio Oncology Therapeutics
×6Alex: together at Putnam Associates
Contact· published on Alex's own website
Experience
- Brandon CapitalPrincipal | Investment Teamcurrent2025 — presentMelbourne, Victoria, Australia
- BridgeBio Oncology TherapeuticsBoard Observer2024 — 2025
- NRG TherapeuticsBoard Observer2022 — 2025
- Omega FundsSenior Investment Associate2021 — 2025Boston, Massachusetts, United States
- Scorpion TherapeuticsBoard Observer2022 — 2025
- Photys TherapeuticsBoard Observer2022 — 2023
- Putnam AssociatesConsultant2019 — 2021Boston, Massachusetts, United States
- BiogenPostdoctoral Scientist - Multiple Sclerosis and Neuroimmunology Research Unit2016 — 2019Cambridge, MA, USA
- BiogenInternship - Business Development and Licensing (BD&L)2018 — 2019Cambridge, MA, USA
- Walter and Eliza Hall Institute of Medical ResearchPostdoctoral researcher - Strasser/Herold Laboratories2014 — 2016Melbourne, Australia
- Walter and Eliza Hall Institute of Medical ResearchBusiness Development Intern2013 — 2016Melbourne, Australia
- Brandon CapitalMedical Research Commercialisation Fund - VC Internship2015Melbourne, Australia
- Cancer Therapeutics CRC (CTx)Molecules to Medicine Internship2013 — 2014Melbourne, Australia
Skills & more
Collaborative Problem SolvingMolecular Biology13Immunology6Cell Biology9Flow Cytometry3Biochemistry4Cell Culture4Cancer Research1Mouse ModelsCancer BiologyProject ManagementInterdisciplinary Collaboration
+3 more
HematopoiesisInternal CommunicationsScientific WritingFrom Alex's professional profile.
Colleagues at Omega Funds
Anne-Mari Paster
General Partner at Omega Funds
Annie Mitsak
Partner at Cure Ventures
Benjamin Youn
Associate at Omega Funds
Bernard Davitian
Partner at Omega Funds
Claudio Nessi
Managing Director at Omega Funds
Deirdre Cunnane
COO, General Counsel at Omega Funds
Francesco Draetta
Managing Director at Omega Funds
Katie Kerfoot
Vice President at Omega Funds
Network6
Annie Mitsak
Partner at Cure Ventures
Bernard Davitian
Partner at Omega Funds
Francesco Draetta
Managing Director at Omega Funds
Katie Kerfoot
Vice President at Omega Funds
Michael Powell
Partner at Omega Funds
Thomas Goebel
Principal at Omega Funds
Investors connected to Alex in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Alex Delbridge?
- Senior Associate at Omega Funds
- Where does Alex Delbridge work?
- Alex Delbridge is Associate at Omega Funds.
- What check size does Alex Delbridge write?
- Alex Delbridge typically writes checks of $100K – $5M.
- Where did Alex Delbridge go to school?
- Alex Delbridge studied at University of Melbourne (Doctor of Philosophy (Ph.D.), Oncology and Cancer Biology); Harvard Business School Online (CORe - Credential of Readiness); University of Melbourne (Graduate Certificate in Advanced Learning and Leadership, Leadership).
Same school
Also attended University of Melbourne384
Cameron AdamsCo-founder & Chief Product Officer of CanvaKevin JohnsonInvestor at MedicxiEsther GilmoreGlobal Head of the Client Team at Generation Investment ManagementMark MillsClient Team Member at Generation Investment ManagementPaulInvestor at Square Peg CapitalClarissa KartikaAssociate, Investment at Vertex Ventures Sea Management Pte. Ltd.
+ 378 more
Also attended Harvard Business School Online292
MariaInvestor at InvestinorKelsey BeausoleilBusiness Development Network at Redpoint VenturesOliver MarquesPartner, Capital Formation at March Capital PartnersJohn DemeterInvestor at Khosla VenturesJeff RoseAdvisor at AI CapitalRobAdvisor at TFX Capital
+ 286 more
Shared employers
Also worked at BridgeBio Oncology Therapeutics3
Also worked at Omega Funds21
Nessan BerminghamInvestor at Khosla VenturesLiam FlahertyInvestor at Silversmith Capital PartnersRichard LimManaging Partner at Cure VenturesAnnie MitsakPartner at Cure VenturesJohn MaraganoreAdvisor at Oak HC/FTWalter StockingerManaging Partner at Hadean Ventures
+ 15 more
Also worked at Scorpion Therapeutics7
Rami RahalPartner at MPM BioImpactAnnie MitsakPartner at Cure VenturesPaulina HillPartner at Sanofi VenturesDr Arjun GoyalInvestment committee member at Tin Alley VenturesDr. Guy PadburySVP, Oncology Clinical Pharmacology at Illinois VenturesDarrin StuartExecutive Officer at Scorpion Therapeutics
+ 1 more
Also worked at Putnam Associates21
Elena VibochManaging Director at General CatalystKathryn ReddyPrincipal at .406 VenturesTara SullivanPrincipal at Flare Capital PartnersJake BauerVenture Partner at ARCH Venture PartnersCharles White, Ph.D.Principal at Illumina VenturesPeter EmighFounder & President, Savoy Life at Red Cell Incubation
+ 15 more










































